(Q53931267)

English

[Quinolones].

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

1 reference

Europe PubMed Central

[Quinolones]. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

0 references

author name string

Juan-Ignacio Alós

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

Infectious Diseases and Clinical Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

21

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

261-7; quiz 268, 272

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical use of the fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical role of protein binding of quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of action of antimicrobials: focus on fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The DNA Gyrase-Quinolone Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quinolone resistance from a transferable plasmid.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of plasmid-mediated quinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The expanding role of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and treatment of traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Parenteral Followed by Oral Ofloxacin for Nosocomial Pneumonia and Community-acquired Pneumonia Requiring Hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of macrolide resistance during treatment of pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of drug-resistant pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ciprofloxacin in patients with bacteremic infections. The Spanish Group for the Study of Ciprofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Do the quinolones still constitute valid empirical therapy for community-acquired urinary tract infections in Spain?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to quinolones in gram-negative microorganisms: mechanisms and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative tolerability of the newer fluoroquinolone antibacterials

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972932-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0213-005X(03)72932-2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

release_m7d7mleyanespd23ya5dn53xpm

1 reference

https://api.fatcat.wiki/v0/release/m7d7mleyanespd23ya5dn53xpm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/12732116

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53931267&oldid=1843781040"